Tatjana Terzic

Prof. Dr. Tatjana Terzic

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2008 in Oral Diseases
Verified
Journal Article
Closed access
PDF file
VJVladimir Jurisic
Vladimir Jurisic
Tatjana TerzicTatjana Terzic
Tatjana Terzic
SCS Colic
S Colic
MJM Jurisic
M Jurisic

17 November 2021 in Life
Verified
Journal Article
Open access
PDF file
MPMirjana Zoran Prvanovic
Mirjana Zoran Prvanovic
MNMilica Nedeljković
Milica Nedeljković
NTNasta Tanić
Nasta Tanić
TTTijana Tomic
Tijana Tomic
Tatjana TerzicTatjana Terzic
Tatjana Terzic
NTNikola Tanic
Nikola Tanic
Breast cancer is the most commonly occurring malignancy and the leading cause of cancer-related death in women. Triple-negative breast cancer (TNBC) is the most aggressive subtype and is associated with high recurrence rates, high incidence of distant metastases, and poor overall survival. The aim of this study was to investigate the PI3K/PTEN/Akt/mTOR pathway as one of the most frequently deregulated pathways in cancer. We aimed to explore the impact of PI3K and mTOR oncogenes as well as the PTEN tumor suppressor on TNBC clinical behavior, prognosis, and multidrug resistance (MDR), using immunohistochemistry and copy number analysis by quantitative real-time PCR. Our results revealed that loss of PTEN and high expression of PI3K and mTOR proteins are associated with poor outcome of TNBC patients. PTEN deletions appeared as a major cause of reduced or absent PTEN expression in TNBC. Importantly, homozygous deletions of PTEN (and not hemizygous deletions) are a potential molecular marker of metastasis formation and good predictors of TNBC outcome. In conclusion, we believe that concurrent examination of PTEN/PI3K/mTOR protein expression may be more useful in predicting TNBC clinical course than the analysis of single protein expression. Specifically, our results showed that PTEN-reduced/PI3K-high/mTOR-high expression constitutes a ‘high risk’ profile of TNBC.

1 February 2008 in Pathology - Research and Practice
Verified
Journal Article
Closed access
VJVladimir Jurisic
Vladimir Jurisic
Tatjana TerzicTatjana Terzic
Tatjana Terzic
SPSonja Pavlovic
Sonja Pavlovic
NCNatasa Colovic
Natasa Colovic
MCMilica Colovic
Milica Colovic

3 June 2009 in Archives of Dermatological Research
Verified
Journal Article
Closed access
PDF file
NCNatasa Colovic
Natasa Colovic
VJVladimir Jurisic
Vladimir Jurisic
Tatjana TerzicTatjana Terzic
Tatjana Terzic
Henry Dushan AtkinsonHenry Dushan Atkinson
Henry Dushan Atkinson
MCMilica Colovic
Milica Colovic

20 March 2023 in Fractal and Fractional
Verified
Journal Article
Open access
PDF file
Igor PanticIgor Pantic
Igor Pantic
Svetlana ValjarevicSvetlana Valjarevic
Svetlana Valjarevic
JCJelena Cumic
Jelena Cumic
IPIvana Paunkovic
Ivana Paunkovic
Tatjana TerzicTatjana Terzic
Tatjana Terzic
Peter R. CorridonPeter R. Corridon
Peter R. Corridon
In this work, we demonstrate that it is possible to create supervised machine-learning models using a support vector machine and random forest algorithms to separate yeast cells exposed to hyperosmotic stress from intact cells. We performed fractal, gray level co-occurrence matrix (GLCM), and discrete wavelet transform analyses on digital micrographs of nuclear regions of interest of a total of 2000 Saccharomyces cerevisiae cells: 1000 exposed to hyperosmotic environments and 1000 control cells. For each nucleus, we calculated values for fractal dimension, angular second moment, inverse difference moment, textural contrast, correlation feature, textural variance, and discrete wavelet coefficient energy. The support vector machine achieved an acceptable classification accuracy of 71.7% in predicting whether the cell belonged to the experimental or control group. The random forest model performed better than the support vector machine, with a classification accuracy of 79.8%. These findings can serve as a starting point for developing AI-based methods that use GLCM, fractal, and wavelet data to classify damaged and healthy cells and make predictions about various physiological and pathological phenomena associated with osmotic stress.

13 May 2014 in Polish Journal of Pathology
Verified
Journal Article
Open access
MCMilica ČoLović
Milica ČoLović
MTMilena Todorović
Milena Todorović
NCNatasa ČoLović
Natasa ČoLović
Tatjana TerzicTatjana Terzic
Tatjana Terzic
KKKatarina Karadzic
Katarina Karadzic
VJVladimir Jurisic
Vladimir Jurisic
Immunosuppressive therapy is one of the standard therapy protocols for aplastic anemia (AA). However, immunosuppressive therapy and androgenic steroids can promote development of solid tumors such as squamous carcinoma, head and neck tumors, adenocarcinoma of the stomach, hepatocarcinoma and breast carcinoma in long surviving patients with aplastic anemia. We present here a rare case of a 56-year-old woman in whom bilateral adenocarcinoma of the breast developed 11 years after the start of immunosuppressive and androgenic steroid therapy for aplastic anemia. Histological examination showed invasive ductal carcinoma with intense nuclear staining for estrogen receptors. Her2 immunohistochemistry was positive for 80% of stained cells, and chromogenic in situ hybridization showed a high level of HER2 gene amplification. This case indicated that a new therapy option is needed for estimation and evaluation to avoid the consequence of cancer occurrence.